高级检索
当前位置: 首页 > 详情页

Cancer Focus Lipid metabolism and cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 自然指数

机构: [1]Qingdao Univ, Affiliated Hosp, Canc Inst, Qingdao, Peoples R China [2]Qingdao Canc Inst, Qingdao, Peoples R China [3]Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol,Natl Clin Res Ctr Oral D, Res Unit Oral Carcinogenesis & Management,Chinese, Chengdu, Peoples R China [4]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Peoples R China [5]Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou, Peoples R China [6]Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China [7]Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China
出处:
ISSN:

摘要:
Dysregulation in lipid metabolism is among the most prominent metabolic alterations in cancer. Cancer cells harness lipid metabolism to obtain energy, components for biological membranes, and signaling molecules needed for proliferation, survival, invasion, metastasis, and response to the tumor microenvironment impact and cancer therapy. Here, we summarize and discuss current knowledge about the advances made in understanding the regulation of lipid metabolism in cancer cells and introduce different approaches that have been clinically used to disrupt lipid metabolism in cancer therapy.

基金:
语种:
高被引:
热点:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 1 区 医学
小类 | 1 区 免疫学 1 区 医学:研究与实验
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 免疫学 1 区 医学:研究与实验
JCR分区:
出版当年[2021]版:
Q1 IMMUNOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 IMMUNOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Qingdao Univ, Affiliated Hosp, Canc Inst, Qingdao, Peoples R China [2]Qingdao Canc Inst, Qingdao, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46425 今日访问量:0 总访问量:3323 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号